Page last updated: 2024-10-25

chlorthalidone and Anterior Circulation Transient Ischemic Attack

chlorthalidone has been researched along with Anterior Circulation Transient Ischemic Attack in 2 studies

Chlorthalidone: A benzenesulfonamide-phthalimidine that tautomerizes to a BENZOPHENONES form. It is considered a thiazide-like diuretic.

Research Excerpts

ExcerptRelevanceReference
"Incident stroke was significantly decreased by treatment in the Systolic Hypertension in Elderly Program (SHEP) Trial, but the reduction in fatal events was not statistically significant."2.73Long-term fatal outcomes in subjects with stroke or transient ischemic attack: fourteen-year follow-up of the systolic hypertension in the elderly program. ( Davis, BR; Kostis, JB; Patel, AB; Pressel, SL; Shea, ML; Wilson, AC, 2008)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bath, PM1
Geeganage, CM1
Gray, LJ1
Patel, AB1
Kostis, JB1
Wilson, AC1
Shea, ML1
Pressel, SL1
Davis, BR1

Trials

1 trial available for chlorthalidone and Anterior Circulation Transient Ischemic Attack

ArticleYear
Long-term fatal outcomes in subjects with stroke or transient ischemic attack: fourteen-year follow-up of the systolic hypertension in the elderly program.
    Stroke, 2008, Volume: 39, Issue:4

    Topics: Adult; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Cause of Death; Chlorthalidone; F

2008

Other Studies

1 other study available for chlorthalidone and Anterior Circulation Transient Ischemic Attack

ArticleYear
Ordinal reanalysis of the SHEP trial.
    Stroke, 2008, Volume: 39, Issue:9

    Topics: Antihypertensive Agents; Chlorthalidone; Clinical Trials as Topic; Data Interpretation, Statistical;

2008